A portable technology that gently applies a custom “second skin” to minimize discomfort and speed up recovery.
40+countries where Spincare is sold
2018founded, a spin-off of Nicast
7peer-reviewed publications
Q3 2020Spincare introduced to the market
About Nanomedic
Nanomedic Technologies Ltd. is a bio-medical therapeutics technology company specializing in the development and manufacturing of its innovative Spincare System platform for advanced wound treatment.
Founded in 2018 as a spinoff of Nicast, a pioneer in electrospinning technology, Nanomedic concentrates on its unique Portable Electrospinning technology platform, the Spincare system.
The company, situated in the heart of a renowned microenvironment of innovative companies, has set a goal to revolutionize wound care treatment, envisioning the ultimate solution of 3D printing artificial skin directly on patients’ wounds.
The Spincare system was first introduced to the market in Q3 2020 and is now distributed and sold in more than 40 countries across five continents.
How portable electrospinning works
- 1
A sterile polymer solution
A single-use ampoule of proprietary polymer solution is loaded into the handheld device.
- 2
An electrostatic field draws the fibres
Electrostatic forces pull the solution into fibres a few hundred nanometres thick, without the device touching the patient.
- 3
The matrix forms on the wound
The fibres settle into a transparent, breathable skin-like layer that conforms to the wound and needs no fixation.
The Spincare System
A handheld, battery-powered device that prints a temporary skin substitute directly onto superficial and partial-thickness wounds, in a single application and without contact.
BiocompatibleTransparentHighly porousPermeableBreathable
- Fully personalized and tailored to patient condition, wound size and geometry (makes hard, easy)
- Facilitates proliferation and migration of cells
- Excellent skin quality and scarring results reported
- Reduces risk of infection
Leadership
The people behind Nanomedic, its board, and the scientific advisors guiding the clinical programme.
Partner in Om-Maya, a private equity firm. Management experience in a multinational corporation, with a focus on management and operations, and information management.Full profile →
Gideon PetroverCEO
Dr. Barzilay has over 20 years of recognized research and development experience in the field of Pharma, Biotech, and Medical Devices. Before joining Nanomedic, Claudia served as Project Manager, Scientific Advisor, and VP R&D in local and global biotech and cleantech companies, gaining broad knowledge in Product Development. She received her Ph.D. in Chemistry from the Technion - Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA, USA, and achieved a Researcher and Lecturer position at the Faculty of Medicine, Hebrew University of Jerusalem.Full profile →
Dr. Claudia M. BarzilayCTO
Mr. Morris has more than 25 years of managerial, financial, and operations experience and has expertise in complex financial arrangements dealing with private investment, disposition of assets, WOFEs, and joint ventures. Chanan has spent the last 16 years managing many of the Infinity group's top portfolio companies, and today also serves as the CFO of Imed Infinity Medical (TASE: IMED). Chanan holds a BSc in Accounting from Northeastern University (USA).Full profile →
Chanan MorrisVP Finance
Mr. Zilberstein has more than 24 years of experience in the establishment and management of quality and regulatory assurance activities in the global medical device industry.
Before joining Nanomedic, Asher served as the QA/RA leader in several medical device companies, such as Endospan (endovascular aortic repair system), and Edwards' acquired Valtech Cardio (transcatheter repair of heart valves). Asher holds a Master of Science (MSc) in Biotechnology from the Hebrew University in Jerusalem, Israel.Full profile →
Asher ZilbersteinVP QA/RA
Dr. Roni Koren brings over 20 years of global experience in business development, marketing, and commercial strategy across healthcare, life sciences, and technology. She specializes in translating breakthrough medical innovations into scalable, market-ready solutions.
Roni has led successful go-to-market efforts for digital health and medtech ventures across Europe, the U.S., APAC, and Israel, building strategic partnerships and investor relations that generated multi-million dollar pipelines.Full profile →
Dr. Roni KorenHead of Global Sales & Marketing
Liron holds a Ph.D. in Chemical Engineering and brings nearly 20 years of experience in the medical device and drug–device combination product space. As a senior executive and trusted member of leadership teams, she possesses multidisciplinary expertise across medical, software, hardware, and regulatory domains.Full profile →
Liron HadarVP Clinical and US Regulation
Lior holds a BSc in Biotechnology Engineering and an MSc in Environmental Engineering. He brings more than 14 years of experience in manufacturing, operations, and logistics management, with a strong focus on process optimization and organizational efficiency.Full profile →
Lior BergerOperation manager
The CEO of TechnoPlus Venture, a diversified public investment company, has traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz possesses extensive experience in managing investments in companies and ventures of all maturity levels.Full profile →
Chen KatzActive Chairman
A seasoned private equity investor and business leader with extensive experience in investing and listing companies on the NSE, Shanghai, Singapore and NASDAQ exchanges.Full profile →
Shankar VaradharajanDirector
Technologist & Investor with 20+ years of leadership experience with Fortune 500 companies like Robert Bosch & Stanley Black + Decker. Currently managing a portfolio of investments in the Med-Tech, Ed-Tech & Green-tech segments.Full profile →
Satish AnantharamanDirector
Partner in Om-Maya, a private equity firm. Management experience in a multinational corporation, with a focus on management and operations, and information management.Full profile →
Gideon PetroverCEO
Accomplished leadership coach in Business Strategy and Business Transformation, and professor of practice in Change Management, teaching at leading business schools in India, China, and Australia.Full profile →
Prof. CB MohanDirector
Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive Surgery at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan, Israel, affiliated with Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy, and has been a specialist in plastic surgery since 2002. Prof Haik completed a fellowship in Plastic Surgery in Sao Paulo, Brazil, and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master's Degree in Public Health (MPH), disaster management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member of the Israeli Association for Aesthetic Plastic Surgery, the Israel Medical Association, the International Association for Aesthetic Surgery, and the Israeli Association for Healing Wounds.Full profile →
Professor Josef Haik, M.D, MPHScientific advisor
Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.Full profile →
Professor Jan Plock, M.D.Scientific advisor
With more than 35 years of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for KCI. In this 3M affiliate, he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.Full profile →
John R. Harper, Ph.DScientific advisor
